Formation of neutralizing antibodies during therapy of multiple sclerosis with interferon beta-1b. Practical procedure when treatment failure is suspected;Bildung von neutralisierenden antikorpern unter therapie der multiplen sklerose mit interferon beta-1b. Praktisches vorgehen bei verdacht auf therapieversagen

Nervenarzt

Volumn 68, Issue 12, 1997, Pages 935-939

  Walther, E U ^a   Dang, T ^a   Hartung, H P ^b   Hohlfeld, R ^a,c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c Max Planck Institut   (Germany)

Author keywords

Interferon beta; Multiple sclerosis; Neutralizing antibodies; Therapy

Indexed keywords

INTERFERON BETA SERINE; NEUTRALIZING ANTIBODY; PLACEBO; BETA INTERFERON; BETA1A INTERFERON; IMMUNOLOGICAL ADJUVANT; INTERFERON BETA-1B;

ARTICLE; CLINICAL TRIAL; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIPLE SCLEROSIS; PRACTICE GUIDELINE; TREATMENT FAILURE; ANTIBODY PRODUCTION; DRUG EFFECT; IMMUNOLOGY; NEUROLOGIC EXAMINATION; REVIEW; SERODIAGNOSIS;

ADJUVANTS, IMMUNOLOGIC; ANTIBODY FORMATION; HUMANS; INTERFERON-BETA; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; NEUTRALIZATION TESTS; TREATMENT FAILURE;

EID: 0031283137     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001150050219     Document Type: Article

References (16)

1. Alam J (1995) Anhörung des Drug Advisory Comittee der FDA zu Interferon beta-1a (Avonex™, Biogen) am 4.12.1995 in Rockville, MD, USA
2. Betaseron® (Interferon beta-1b), amerikanische Packungsbeilage. Berlex Laboratories, Richmond, CA:Juli 1993
3. Calabresi PA, Frank JA, Maloni HW, Bash CN, Stone LA, McFarland HF (1997) Association between neutralizing antibodies to Interferon beta and contrast enhancing lesions in multiple sclerosis patients. Neurology 48:A80
4. Goetschy JF, Zeller H, Content J, Horisberger MA (1989) Regulation of the interferon-inducible IFI-78K gene, the human equivalent of the murine Mx gene, by interferons, doublestranded RNA, certain cytokines and viruses. J Virol 68:2616-2622
5. Hartung HP, Hohlfeld R (1994) Interferon-β zur Behandlung der schubförmig verlaufenden Multiplen Sklerose. Nervenarzt 65:139-145
6. Jacobs LD, Cookfair OL, Rudick RA et al. und The Multiple Sclerosis Collaborative Research Group (MSCRG) (1996) Intermuscular Interferon beta-1 a for disease progression in relapsing multiple sclerosis. Ann Neurol 39:285-294
7. Kurtzke JF (1983) Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444-1452
8. Pachner AR (1997) Anticytokine antibodies in beta interferon-treated MS patients and the need for testing: Plight of the practicing neurologist. Neurology 49:647-650
9. Paty DW, Li DKB, the UBC MS/MRI Study Group, the IFNB Multiple Sclerosis Study Group (1993) Interferon beta-1 b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43:662-667
10. Paty DW, Goodkin D, Thompson A, Rice G (1996) Guidelines for physicians with patients on IFNβ-1b: the use of an assay for neutralizing antibodies (NAB). Neurology 47:865-866
11. Rudick RA, Jones W, Alam J et al. und The Multiple Sclerosis Collaborative Research Group (1997) Significance of serum neutralizing antibodies to Avonex™ (IFN beta-1a) in multiple sclerosis. Neurology 48:A80
12. The IFNB Multiple Sclerosis Study Group (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I.Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43-655-661
13. The IFNB Multiple Sclerosis Study Group and the UBC MS/MRI Analysis Group (1995) Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. Neurology 45:1277-1285
14. The IFNB Multiple Sclerosis Study Group and the UBC MS/MRI Analysis Group (1996) Neutralizing antibodies during treatment of multiple sclerosis with interferon beta-1b: experience during the first three years. Neurology 47:889-894
15. Towbin H, Schmitz A, Jakschies D, von Wussow P, Horisberger MA (1992) A whole blood immunoassay for the interferon-inducible human Mx-protein. J Interferon Res 12:67-74
16. von Wussow P, Jakschies D, Hochkeppel HK, Fibich C, Penner L, Deicher H (1990) The human intracellular Mx-homologous protein is specifically induced by type-l interferons. Eur J Immunol 20:2015-2019